Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

NCT00551239 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: fludarabine phosphate
DRUG: pixantrone dimaleate

Sponsor

CTI BioPharma